EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine

Jeewanjot Singh iD, Devinder Kumar

Journal of Food and Drug Analysis · 17.09.2025 · 33 (3) · 193-212

DOI: 10.38212/2224-6614.3557 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 17.09.2025. Verfasst von Jeewanjot Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, 140111, India. Hauptthemen laut MEDLINE: Parkinson Disease, Phytochemicals, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by dopaminergic neuronal loss,oxidative stress, neuroinflammation, and a-synuclein aggregation. Despite advances, current treatments only offersymptomatic relief without altering disease progression. This review aims to evaluate the therapeutic potential of plant-derived phytochemicals in PD through evidence from both in vivo and in vitro experimental models. Key findingsindicate that rodent models (e.g., MPTP, rotenone) and neuronal cell lines (e.g., SH-SY5Y) help replicate PD pathologyand mechanistic insights. Phytochemicals such as baicalein, morin, ferulic acid, and bacopa demonstrate neuroprotectiveeffects via antioxidant, anti-inflammatory, and mitochondrial-stabilizing pathways. Nanotechnology and brain orga-noids further improve translational relevance. In conclusion, phytomedicines hold significant promise as adjunctive PDtherapies. However, challenges such as poor bioavailability, model variability, and lack of clinical validation must be addressed through standardized protocols and long-term studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePhytochemicalsPlant ExtractsHumansAnimalsNeuroprotective AgentsDisease Models, Animal

Substanzen

Neuroprotective AgentsPhytochemicalsPlant Extracts

Autor:innen und Institutionen

  • Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, 140111, India.

ORCID-Profile: Jeewanjot Singh

Zitieren

APA

Singh, J., & Kumar, D. (2025). In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine. Journal of Food and Drug Analysis, 33(3), 193-212. https://doi.org/10.38212/2224-6614.3557

Vancouver

Singh J, Kumar D. In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine. Journal of Food and Drug Analysis. 2025;33(3):193-212. doi:10.38212/2224-6614.3557

BibTeX
@article{Singh2025,
  author = {Singh, Jeewanjot and Kumar, Devinder},
  title = {In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine},
  journal = {Journal of Food and Drug Analysis},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {193--212},
  doi = {10.38212/2224-6614.3557}
}
Kostenlos starten →